Management of airway mucus hypersecretion in chronic airway inflammatory disease: Chinese expert consensus (English edition)

References

• FahyJVDickeyBFAirway mucus function and dysfunctionN Engl J Med2010363232233224721121836
   PubMed Web of Science ®Google Scholar
• CurranDRCohnLAdvances in mucous cell metaplasia: a plug for mucus as a therapeutic focus in chronic airway diseaseAm J Respir Cell Mol Biol201042326827519520914
   PubMed Web of Science ®Google Scholar
• CerveriIBrusascoVRevisited role for mucus hypersecretion in the pathogenesis of COPDEur Respir Rev20101911610911220956178
   PubMedGoogle Scholar
• WenFQShenYCExpectorant therapy revisited in chronic obstructive pulmonary diseaseZhonghua Jie He He Hu Xi Za Zhi2011344243245 Chinese21609602
   PubMedGoogle Scholar
• RogersDFMucoactive agents for airway mucus hypersecretory diseasesRespir Care20075291176119317716385
   PubMed Web of Science ®Google Scholar
• HensonPMDampening inflammationNat Immunol20056121179118116369556
   PubMed Web of Science ®Google Scholar
• KorfhagenTRKitzmillerJChenGSAM-pointed domain ETS factor mediates epithelial cell-intrinsic innate immune signaling during airway mucous metaplasiaProc Natl Acad Sci U S A201210941166301663523012424
   PubMed Web of Science ®Google Scholar
• HoltzmanMJByersDEAlexander-BrettJWangXThe role of airway epithelial cells and innate immune cells in chronic respiratory diseaseNat Rev Immunol2014141068669825234144
   PubMed Web of Science ®Google Scholar
• TynerJWKimEYIdeKBlocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signalsJ Clin Invest2006116230932116453019
   PubMed Web of Science ®Google Scholar
• DijkstraAEBoezenHMvan den BergeMDissecting the genetics of chronic mucus hypersecretion in smokers with and without COPDEur Respir J2015451607525234806
   PubMed Web of Science ®Google Scholar
• ChandHSMontanoGHuangXA genetic variant of p53 restricts the mucous secretory phenotype by regulating SPDEF and Bcl-2 expressionNat Commun20145556725429397
   PubMed Web of Science ®Google Scholar
• AllinsonJPHardyRDonaldsonGCShaheenSOKuhDWedzichaJAThe presence of chronic mucus hypersecretion across adult life in relation to chronic obstructive pulmonary disease developmentAm J Respir Crit Care Med2016193666267226695373
   PubMed Web of Science ®Google Scholar
• ReidKBClarkHPalaniyarNSurfactant and lung inflammationThorax200560862062216061700
   PubMed Web of Science ®Google Scholar
• COPD group of Chinese Thoracic SocietyGuideline for diagnosis and treatment of chronic obstructive pulmonary disease (updated 2013)Zhonghua Jie He He Hu Xi Za Zhi2013364255265 Chinese
   Google Scholar
• ZhongNWangCYaoWPrevalence of chronic obstructive pulmonary disease in China: a large, population-based surveyAm J Respir Crit Care Med2007176875376017575095
   PubMed Web of Science ®Google Scholar
• de MarcoRAccordiniSCerveriIIncidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegmAm J Respir Crit Care Med20071751323917008642
   PubMed Web of Science ®Google Scholar
• YamaneTHattoriNKitaharaYProductive cough is an independent risk factor for the development of COPD in former smokersRespirology201015231331820070589
   PubMed Web of Science ®Google Scholar
• MaRWangYChenGZhangHZWanHYHuangSGGoblet cell hyperplasia and abnormalities in mucin expression in COPD patientsShanghai Di Er Yi Ke Da Xue Xue Bao20042412103110331044 Chinese
   Google Scholar
• MiravitllesMGuerreroTMayordomoCSánchez-AgudoLNicolauFSegúJLFactors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study GroupRespiration200067549550111070451
   PubMed Web of Science ®Google Scholar
• HoggJCChuFSTanWCSurvival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathologyAm J Respir Crit Care Med2007176545445917556723
   PubMed Web of Science ®Google Scholar
• BurgelPRNesme-MeyerPChanezPCough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjectsChest2009135497598219017866
   PubMed Web of Science ®Google Scholar
• WedzichaJASinghRMackayAJAcute COPD exacerbationsClin Chest Med201435115716324507843
   PubMed Web of Science ®Google Scholar
• WedzichaJAMechanisms of chronic obstructive pulmonary disease exacerbationsAnn Am Thorac Soc201512Suppl 2S157S159
   Web of Science ®Google Scholar
• ZhangWLuHPengLChronic bronchitis leads to accelerated hyperinflation in COPD patients during exerciseRespirology201520461862525799924
   PubMed Web of Science ®Google Scholar
• MeekPMPetersenHWashkoGRChronic bronchitis is associated with worse symptoms and quality of life than chronic airflow obstructionChest2015148240841625741880
   PubMed Web of Science ®Google Scholar
• MiravitllesMCough and sputum production as risk factors for poor outcomes in patients with COPDRespir Med201110581118112821353517
   PubMed Web of Science ®Google Scholar
• Asthma Workgroup, Chinese Thoracic Society, Chinese Society of General PractitionersChinese guideline for the prevention and management of bronchial asthma (Primary Health Care Version)J Thorac Dis20135566767724255781
   PubMed Web of Science ®Google Scholar
• Del DonnoMBittesnichDChettaAOlivieriDLopez-VidrieroMTThe effect of inflammation on mucociliary clearance in asthma: an overviewChest200011841142114911035690
   PubMed Web of Science ®Google Scholar
• de MarcoRMarconAJarvisDPrognostic factors of asthma severity: a 9-year international prospective cohort studyJ Allergy Clin Immunol200611761249125616750983
   PubMed Web of Science ®Google Scholar
• ThomsonNCChaudhuriRMessowCMChronic cough and sputum production are associated with worse clinical outcomes in stable asthmaRespir Med2013107101501150823927851
   PubMed Web of Science ®Google Scholar
• SirouxVBoudierABousquetJPhenotypic determinants of uncontrolled asthmaJ Allergy Clin Immunol20091244681687.e319665764
   PubMed Web of Science ®Google Scholar
• KuyperLMParéPDHoggJCCharacterization of airway plugging in fatal asthmaAm J Med2003115161112867228
   PubMed Web of Science ®Google Scholar
• AikawaTShimuraSSasakiHEbinaMTakishimaTMarked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attackChest199210149169211555462
   PubMed Web of Science ®Google Scholar
• Workgroup of bronchiectasis diagnosis and managementExpert consensus on diagnosis and management of adult bronchiectasisZhonghua Jie He He Hu Xi Za Zhi2012357485492 Chinese
   Google Scholar
• TambascioJde SouzaHCMartinezJAAfonsoJLJardimJRGastaldiACThe influence of purulence on ciliary and cough transport in bronchiectasisRespir Care201358122101210623674811
   PubMed Web of Science ®Google Scholar
• GoeminnePCVandoorenJMoelantsEAThe Sputum Colour Chart as a predictor of lung inflammation, proteolysis and damage in non-cystic fibrosis bronchiectasis: a case-control analysisRespirology201419220321024286471
   PubMed Web of Science ®Google Scholar
• LiuTWKangJAnalysis of clinical features of cystic fibrosis in ChineseZhong Guo Quan Ke Yi Xue152428072810 Chinese
   Google Scholar
• KredaSMDavisCWRoseMCCFTR, mucins, and mucus obstruction in cystic fibrosisCold Spring Harb Perspect Med201229a00958922951447
   PubMed Web of Science ®Google Scholar
• CrawfordBMonzBHohlfeldJDevelopment and validation of a cough and sputum assessment questionnaireRespir Med2008102111545155518662868
   PubMed Web of Science ®Google Scholar
• MonzBUSachsPMcDonaldJCrawfordBNivensMCTetzlaffKResponsiveness of the cough and sputum assessment questionnaire in exacerbations of COPD and chronic bronchitisRespir Med2010104453454119917525
   PubMed Web of Science ®Google Scholar
• HardinMRennardSIWhat’s new with the St George’s Respiratory Questionnaire and why do we care?Chronic Obstr Pulm Dis201742838628848916
   PubMedGoogle Scholar
• CassidyRNRobertsMEColbySMValidation of a respiratory symptom questionnaire in adolescent smokersTob Regul Sci20151212112826236764
   PubMedGoogle Scholar
• BalsamoRLanataLEganCGMucoactive drugsEur Respir Rev20101911612713320956181
   PubMedGoogle Scholar
• DonaldsonSHBennettWDZemanKLKnowlesMRTarranRBoucherRCMucus clearance and lung function in cystic fibrosis with hypertonic salineN Engl J Med2006354324125016421365
   PubMed Web of Science ®Google Scholar
• ElkinsMRRobinsonMRoseBRA controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosisN Engl J Med2006354322924016421364
   PubMed Web of Science ®Google Scholar
• KellettFRobertNMNebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasisRespir Med2011105121831183522018993
   PubMed Web of Science ®Google Scholar
• GraeberSYZhou-SuckowZSchatternyJHirtzSBoucherRCMallMAHypertonic saline is effective in the prevention and treatment of mucus obstruction, but not airway inflammation, in mice with chronic obstructive lung diseaseAm J Respir Cell Mol Biol201349341041723590312
   PubMed Web of Science ®Google Scholar
• TaubeCHolzOMückeMJörresRAMagnussenHAirway response to inhaled hypertonic saline in patients with moderate to severe chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200116410 Pt 11810181511734428
   PubMed Web of Science ®Google Scholar
• ZhengJPKangJHuangSGEffect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled studyLancet200837196292013201818555912
   PubMed Web of Science ®Google Scholar
• YasudaHYamayaMSasakiTCarbocisteine reduces frequency of common colds and exacerbations in patients with chronic obstructive pulmonary diseaseJ Am Geriatr Soc200654237838016460403
   PubMed Web of Science ®Google Scholar
• IshiuraYFujimuraMYamamoriCEffect of carbocysteine on cough reflex to capsaicin in asthmatic patientsBr J Clin Pharmacol200355650451012814442
   PubMed Web of Science ®Google Scholar
• LingLLinJTAnti-inflammatory role of macrolides on respiratory diseasesZhong Ri You Hao Yi Yuan Xue Bao2009234247253 Chinese
   Google Scholar
• SeemungalTAWilkinsonTMHurstJRPereraWRSapsfordRJWedzichaJALong-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbationsAm J Respir Crit Care Med2008178111139114718723437
   PubMed Web of Science ®Google Scholar
• AlbertRKConnettJBaileyWCAzithromycin for prevention of exacerbations of COPDN Engl J Med2011365868969821864166
   PubMed Web of Science ®Google Scholar
• YaoGYMaYLZhangMQGaoZCMacrolide therapy decreases chronic obstructive pulmonary disease exacerbation: a meta-analysisRespiration201386325426023817204
   PubMed Web of Science ®Google Scholar
• SpagnoloPFabbriLMBushALong-term macrolide treatment for chronic respiratory diseaseEur Respir J201342123925123180583
   PubMed Web of Science ®Google Scholar
• ReiterJDemirelNMendyAMacrolides for the long-term management of asthma – a meta-analysis of randomized clinical trialsAllergy20136881040104923895667
   PubMed Web of Science ®Google Scholar
• SerisierDJMartinMLMcGuckinMAEffect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trialJAMA2013309121260126723532242
   PubMed Web of Science ®Google Scholar
• AltenburgJde GraaffCSStienstraYEffect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trialJAMA2013309121251125923532241
   PubMed Web of Science ®Google Scholar
• LiuJFZhongXNHeZYImpact of treatment with low dose roxithromycin on stable bronchiectasisZhonghua Jie He He Hu Xi Za Zhi20123511824827 Chinese23290037
   PubMedGoogle Scholar
• ShiZLPengHHuXWHuJGEffectiveness and safety of macrolides in bronchiectasis patients: a meta-analysis and systematic reviewPulm Pharmacol Ther201428217117824076368
   PubMed Web of Science ®Google Scholar
• LiuSXYangLEffect of N-acetylcysteine on SOD, MDA in COPD patients with different stagesZhong Guo Lao Nian Xue Za Zhi200626810281029 Chinese
   Google Scholar
• TseHNRaiteriLWongKYHigh-dose N-acetylcysteine in stable COPD: the 1-year, double-blind, randomized, placebo-controlled HIACE studyChest2013144110611823348146
   PubMed Web of Science ®Google Scholar
• ZhengJPWenFQBaiCXTwice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trialLancet Respir Med20142318719424621680
   PubMed Web of Science ®Google Scholar
• ZhouBQLiXKClinic efficacy of erdosteine on elderly bronchiectasis patients with airway mucus hypersecretionShi Yong Yi Xue Za Zhi201127610661068 Chinese
   Google Scholar
• RheeCKKangCMYouMBEffect of fudosteine on mucin productionEur Respir J20083251195120218579549
   PubMed Web of Science ®Google Scholar
• Ueno-IioTShibakuraMIioKEffect of fudosteine, a cysteine derivative, on airway hyperresponsiveness, inflammation, and remodeling in a murine model of asthmaLife Sci20139220–211015102323583570
   PubMed Web of Science ®Google Scholar
• OsoataGOHanazawaTBrindicciCItoMPeroxynitrite elevation in exhaled breath condensate of COPD and its inhibition by fudosteineChest200913561513152019188555
   PubMed Web of Science ®Google Scholar
• RahmanIMacNeeWAntioxidant pharmacological therapies for COPDCurr Opin Pharmacol201212325626522349417
   PubMed Web of Science ®Google Scholar
• MalerbaMRagnoliBAmbroxol in the 21st century: pharmacological and clinical updateExpert Opin Drug Metab Toxicol2008481119112918680446
   PubMed Web of Science ®Google Scholar
• MalerbaMPonticielloARadaeliABensiGGrassiVEffect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial)Pulm Pharmacol Ther2004171273414643168
   PubMed Web of Science ®Google Scholar
• KuangSGZhangHYZhangJThe effect of ambroxol on oxidation/antioxidant imbalance in AECOPD patientsZhong Hua Nei Ke Za Zhi2001402125126 Chinese
   Google Scholar
• LuQYuJBaoLRanTZhongHEffects of combined treatment with ambroxol and ciprofloxacin on catheter-associated Pseudomonas aeruginosa biofilms in a rat modelChemotherapy2013591515623816803
   PubMed Web of Science ®Google Scholar
• ChenCYLiuHLThe clinical efficacy of intravenous and bronchoalveolar lavage ambroxol for patients with bronchiectasis and infectionZhong Guo She Qu Yi Shi2013156128129 Chinese
   Google Scholar
• CaoLChenYZhaoYEffect of Myrtol standardized on mucus hypersecretion and clearance of Pseudomonas aeruginosa in a rat model of chronic obstructive pulmonary diseaseArzneimittelforschung2011611268569222282955
   PubMed Web of Science ®Google Scholar
• ZhangXXShiTNieXHSystematic review of standardized myrtol in the treatment of COPDZhong Guo Yao Ye20132253639
   Google Scholar
• AraiNKondoMIzumoTTamaokiJNagaiAInhibition of neutrophil elastase-induced goblet cell metaplasia by tiotropium in miceEur Respir J20103551164117119897560
   PubMed Web of Science ®Google Scholar
• TanYFZhangWYangLJiangSPThe effect of formoterol on airway goblet cell hyperplasia and protein Muc5ac expression in asthmatic miceEur Rev Med Pharmacol Sci201115774375021780541
   PubMed Web of Science ®Google Scholar
• MeyerTReitmeirPBrandPEffects of formoterol and tiotropium bromide on mucus clearance in patients with COPDRespir Med2011105690090621397483
   PubMed Web of Science ®Google Scholar
• ZhengYLZengXLTherapeutic effect analysis of Ambroxol in combination with inhaled Combivent on acute exacerbation of chronic obstructive pulmonary diseaseZhong Hua Lao Nina Yi Xue Za Zhi2014331112101211 Chinese
   Google Scholar
• PoolePBlackPNCatesCJMucolytic agents for chronic bronchitis or chronic obstructive pulmonary diseaseCochrane Database Syst Rev20128CD001287
   Google Scholar
• World Health Organization Collaborating Centre for Tobacco or Health, Tobacco Control Office of Chinese Center for Disease Control and Prevention, Chinese Association on Tobacco Control Hospital Smoking Control CommitteeChina clinical smoking cessation guidelines (2007 edition, the Tentative)Guo Ji Hu Xi Za Zhi20082816961970 Chinese
   Google Scholar
• Respiratory Care Group of Chinese Thoracic SocietyExpert consensus on aerosol treatmentZhonghua Jie He He Hu Xi Za Zhi20133711805808 Chinese
   Google Scholar
• FinkJBPositioning versus postural drainageRespir Care200247776977712088547
   PubMedGoogle Scholar
• ChakravortyIChahalKAustinGA pilot study of the impact of high-frequency chest wall oscillation in chronic obstructive pulmonary disease patients with mucus hypersecretionInt J Chron Obstruct Pulmon Dis2011669369922259246
   PubMed Web of Science ®Google Scholar
• VenturelliECrisafulliEDeBiaseAEfficacy of temporary positive expiratory pressure (TPEP) in patients with lung diseases and chronic mucus hypersecretion. The UNIKO® project: a multicentre randomized controlled trialClin Rehabil201327433634622967853
   PubMed Web of Science ®Google Scholar